December 2, 2019
Combo Therapy Shows Modest Survival Gain, More Toxicity for Gastric Cancer Bookmark
Article from Cancer Network curated by Editor in Chief George Lundberg, MD, who notes:
A clinical trial of a combination therapy for gastric cancer showed modest increased overall survival (OS) in one group of patients, but at the cost of increased adverse effects.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.